Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura-Reference-Cited by-同舟云学术

Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura

Published:2020-09-11 Issue:10 Volume:18 Page:2503-2512
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Zheng X. Long¹^ORCID,Vesely Sara K.²,Cataland Spero R.³^ORCID,Coppo Paul⁴,Geldziler Brian⁵,Iorio Alfonso⁶⁷^ORCID,Matsumoto Masanori⁸,Mustafa Reem A.⁹,Pai Menaka⁷,Rock Gail¹⁰,Russell Lene¹¹^ORCID,Tarawneh Rawan¹²,Valdes Julie¹³,Peyvandi Flora¹⁴¹⁵

Affiliation:

1. Department of Pathology and Laboratory Medicine University of Kansas Medical Center Kansas City KS USA

2. Hudson College of Public Health University of Oklahoma Health Sciences Center Oklahoma City OK USA

3. Department of Medicine Ohio State University Columbus OH USA

4. Centre de Référence des Microangiopathies Thrombotiques Service d'Hématologie Hôpital Saint‐Antoine Sorbonne Université, Assistance PubliqueHôpitaux de Paris Paris France

5. Somerset NJ USA

6. Department of Health Research Methods, Research, and Impact McMaster University Hamilton ON Canada

7. Department of Medicine McMaster University Hamilton ON Canada

8. Department of Blood Transfusion Medicine Nara Medical University Kashihara Japan

9. Department of Medicine The University of Kansas Mediccal Center Kansas City KS USA

10. University of Ottawa Ottawa ON Canada

11. Department of Intensive Care Copenhagen University Hospital Copenhagen Denmark

12. Department of Neurology The Ohio State University Wexner Medical Center Columbus OH USA

13. Morristown NJ USA

14. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milan Italy

15. Department of Pathophysiology and Transplantation Università degli Studi di Milano Milan Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15009

Reference92 articles.

1. Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura

2. Improved Survival in Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome

3. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura

4. Thrombotic thrombocytopenic purpura

5. Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Considerations for the Use of the Rapid AcuStar® ADAMTS13 Activity Assay in the Diagnosis of Acute Thrombotic Thrombocytopenic Purpura (TTP);Journal of Clinical Medicine;2024-07-30

2. ADAMTS13 in the New Era of TTP;International Journal of Molecular Sciences;2024-07-26

3. Immune thrombotic thrombocytopenic purpura: clinical suspicion and basic management in emergency departments — an expert review and consensus statement from the Spanish societies of hematology and hemotherapy (SEHH) and emergency medicine (SEMES);Emergencias;2024-07-02

4. IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES.;Mediterranean Journal of Hematology and Infectious Diseases;2024-06-29

5. Iatrogenic hemorrhage and extensive venous thromboembolism during iTTP treatment with caplacizumab—A case report;eJHaem;2024-06-10